Plain-English translation of NCT06211257 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a digital (computer-based) care plan can help patients with advanced soft tissue sarcoma better manage their chemotherapy treatment. All patients will receive standard support and medical care. About half will also get access to a personalized digital care plan—a secure online tool designed to help track side effects, understand their treatment plan, and access information anytime. The study will follow patients for up to 24 months to see if the digital tool reduces severe side effects.
Advanced sarcoma is a serious cancer that often requires strong chemotherapy. Patients managing this treatment can experience difficult side effects and may struggle to stay informed between hospital visits. This trial wants to see if a digital care plan—something patients can access on their computer at home—can help them better understand and manage their treatment.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: a standard care group or a digital care plan group. Both groups receive regular chemotherapy and standard medical support from your hospital team. If you are in the digital care plan group, you will also receive access to a secure online tool where you can view your personalized treatment information, track side effects, and get answers to common questions. You will be followed by your medical team for up to 24 months, through your second line of chemotherapy or until you start a new treatment, whichever comes first.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France